Kimberly-Clark Corporation

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 1,619 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• Kenvue acquisition: PENDING, not closed, as at 17 August 2026. Q2 2026 10-Q Note 4 (Acquisitions), section literally titled 'Pending Acquisition of Kenvue, Inc.': on 2 November 2025 Kimberly-Clark entered into an Agreement and Plan of Merger to acquire all outstanding equity of Kenvue, Inc. for stock and cash consideration, expecting to issue approximately 280 million shares of K-C common stock and pay approximately $6.7 billion in cash; closing requires satisfaction of customary conditions including foreign regulatory approvals, and either party may owe a $1.1 billion termination fee if the deal falls through. During Q2 2026 K-C incurred $109 million ($157 million year to date) of acquisition-related costs and entered $4.3 billion of forward-starting interest rate swaps in anticipation of debt issuance to fund the cash consideration; deferred share issuance costs of $6 million sit in Other current assets pending issuance of the merger shares. No 8-K reporting closing was found in EDGAR's filing list for CIK 0000055785 through 4 August 2026 (the most recent filing), so the deal remains pending as of this research. It is not recorded as a holding here because K-C does not yet hold any Kenvue equity; if and when it closes, Kenvue becomes a consolidated subsidiary, not a cross-holding, and the roughly 280 million new K-C shares to be issued would materially change K-C's own share count and register percentages.
• Kimberly-Clark de Mexico (KCM) resolved: KCM is a genuine minority equity-method stake (47.9% ownership as of 31 Dec 2025, unchanged disclosure in Q2 2026 filings), not a consolidated subsidiary and not KMB common stock. It is KCM's own separately Mexican-listed shares, valued here at the $2.9 billion fair value the FY2025 10-K discloses based on KCM's own quoted market price; no share count is given for K-C's holding.
• A related but separate divestiture, not to be confused with Kenvue: the International Family Care and Professional (IFP) Transaction with Suzano S.A. closed 1 July 2026 (subsequent event to the Q2 2026 10-Q). K-C sold a 51% controlling interest in the IFP Business (now housed in Kimberly-Clark IFP NewCo B.V.) to Suzano for approximately $1.3 billion cash, retaining a 49% equity-method interest with no fair value or share count yet disclosed.
• Register reconciliation on the largest holders. KMB's 2026 proxy statement's own 'more than five percent' beneficial-ownership table (based on stale Schedule 13G/A filings predating the proxy: Vanguard's 13G/A filed 29 Jul 2025, BlackRock's filed 24 Apr 2025, State Street's filed 29 Jan 2024) shows Vanguard at 40,426,736 shares (12.2%), BlackRock at 25,127,582 shares (7.6%), and State Street at 18,321,389 shares (5.4%). The register instead uses each manager's Q2 2026 Form 13F-HR (30 June 2026 position dates) per the research brief, giving Vanguard's successor entities summing to 37,761,344 shares, BlackRock at 32,321,354 shares (materially higher than the stale 13G figure, consistent with a position increase over the intervening year), and State Street at 21,081,552 shares. More recent SC 13G filings were made in 2026 by State Street (12 May 2026), Vanguard Capital Management (30 Apr 2026), BlackRock (13G/A, 24 Apr 2026) and Vanguard Group (13G/A, 27 Mar 2026); these are routine annual updates by the same three passive managers already captured via 13F and were not used as a separate register source since they add no new holder.
• Vanguard case (VANGUARD RULE): Vanguard Group Inc (CIK 0000102909) filed Form 13F-NT (notice, no holdings table) for the quarter ended 30 June 2026, so its position is represented by the sum of its two successor 13F-HR filers, Vanguard Capital Management LLC and Vanguard Portfolio Management LLC, per the brief's 13F-NT case.
• Capital Group: all three named Capital Group entities were checked individually against their own Q2 2026 13F-HR filings. Only Capital Research Global Investors (CIK 0001422848) reported a KMB position, 1,600,380 shares, $175,673,748. Capital World Investors (CIK 0001422849) and Capital International Investors (CIK 0001562230) reported no KMB position in their Q2 2026 13F-HRs. Capital Research Global Investors' position (rank 16 by shares among the checked managers) falls outside the top 12 used for the register and is not included as a row.
• Managers checked but not included in the top 12 register rows, ranked by Q2 2026 13F-HR shares: Northern Trust Corporation (CIK 0000073124), 3,676,773 shares; T. Rowe Price (CIK 0000080255), 2,569,370 shares (its filing reports value in whole dollars per thousand shares, e.g. 2,085,802 shares valued at $228,959 implying $0.11/share; rescaled x1,000 to $228,959,000, consistent with the implied per-share price of the other managers, per the thousands-trap warning; T. Rowe Price's implied price after rescaling, $109.77/share, matches the cluster); Wells Fargo & Company (CIK 0000072971), 2,424,375 shares (a further 431,000 shares notional of a KMB option position was excluded as a derivative); Capital Research Global Investors, 1,600,380 shares; Franklin Resources, Inc. (CIK 0000038777), 1,575,233 shares.
• Implied price per share across all 17 managers checked (value_usd / shares) clusters tightly between $109.4 and $111.0, consistent with KMB's approximate 30 June 2026 quarter-end closing price, confirming no unit or thousands-scale errors remain in the register rows actually used.
• Market capitalisation of $35.82 billion and the $107.69 share price are stockanalysis.com's figures as of 17 August 2026 (intraday, 1:31pm EDT per the page). Cross-check: 332,579,038 shares x $107.69 implies approximately $35.82 billion, matching the reported market cap almost exactly.
• Percentages are computed by this research against 332,579,038 common shares outstanding as of 28 July 2026 (Q2 2026 10-Q cover page), except the two proxy-sourced insider rows, which use the proxy's own denominator of 331,925,766 shares as of the 16 March 2026 record date.
• Self-gate check: summing the twelve non-aggregate, non-insider register rows (Vanguard through JPMorgan) gives 164,638,012 shares against 332,579,038 shares outstanding, or 49.5%, within the acceptable 15 to 55 percent range though above the 25 to 45 percent expectation; the tight per-share price clustering across all 17 managers checked found no evidence of a mixed basis or double-counted holder, so this is recorded as observed rather than force-fitted.